Close
Ismail Jatoi, MD, PhD, FACS
NOTE : If you're an existing patient, please connect via MyChart
-
About Me
About Ismail Jatoi, MD, PhD, FACS
Ismail Jatoi, MD, PhD, FACS, is a professor in the Division of Surgical Oncology and Endocrine Surgery at The University of Texas Health Science Center at San Antonio. He specializes in breast surgical oncology.
He obtained his bachelor's degree from Washington University in St. Louis, Missouri, and his medical and doctorate degrees from St. Louis University. He is a diplomate of the American Board of Surgery and a fellow of the American College of Surgeons. He completed fellowship training in surgical oncology at the Royal Marsden Hospital.
Dr. Jatoi served in the United States military for many years and was a professor of surgery at the Uniformed Services University in Bethesda, Maryland. He retired from the U.S. Army with the rank of colonel.
Gender
- Male
Languages Spoken
- English
-
Credentials
Credentials
Positions
- Professor of Surgery, Division of Surgical Oncology and Endocrine Surgery, University of Texas Health Science Center San Antonio
- Breast Surgical Oncology, UT Health San Antonio MD Anderson Cancer Center
- Dale H. Dorn Chair in Surgery
Certifications
- American Board of Surgery
Education
- Medical School: Saint Louis University School of Medicine
- Fellowship: Surgical Oncology, Royal Marsden Hospital, London, England
- Residency: General Surgery, University of Chicago Hospitals and Clinics, Chicago, IL
- Residency: General Surgery, University of California, San Francisco, CA
- Internship: University of Chicago Medical Center, Chicago, Illinois
- Doctorate: Pharmacology, St. Louis University, St. Louis, MO
- Locations & Contact
-
Research & Publications
Research & Publications
Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers.
Chiang, H. C., Elledge, R., Larson, P., Jatoi, I., Li, R. & Hu, Y.
Breast Cancer (Auckl) 9, 25-29 (2015). PMID: 26052229; PMCID: PMC4454133
Spatiotemporal control of estrogen-responsive transcription in ERalpha-positive breast cancer cells.
Hsu, P. Y., Hsu, H. K., Hsiao, T. H., Ye, Z., Wang, E., Profit, A. L., Jatoi, I., Chen, Y., Kirma, N. B., Jin, V. X., Sharp, Z. D. & Huang, T. H.
Oncogene (2015). PMID: 26300005
Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.
Jatoi, I. & Parsons, H. M.
Breast Cancer Res. Treat. 148, 389-396 (2014) PMID: 25301088; PMCID: PMC4501767
View All Publications - Ismail Jatoi, MD
-
Clinical Trials
Clinical Trials
No Clinical Trials